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The Wiskott–Aldrich syndrome protein directs actin-based
motility by stimulating actin nucleation with the Arp2/3 complex 
Defne Yarar*, Wayne To†, Arie Abo† and Matthew D. Welch* 
Actin polymerization at the cell cortex is thought to
provide the driving force for aspects of cell-shape
change and locomotion. To coordinate cellular
movements, the initiation of actin polymerization is
tightly regulated, both spatially and temporally. The
Wiskott–Aldrich syndrome protein (WASP), encoded by
the gene that is mutated in the immunodeficiency
disorder Wiskott–Aldrich syndrome [1], has been
implicated in the control of actin polymerization in cells
[2–5]. The Arp2/3 complex, an actin-nucleating factor
that consists of seven polypeptide subunits [6–8], was
recently shown to physically interact with WASP [9]. We
sought to determine whether WASP is a cellular
activator of the Arp2/3 complex and found that WASP
stimulates the actin nucleation activity of the Arp2/3
complex in vitro. Moreover, WASP-coated microspheres
polymerized actin, formed actin tails and exhibited
actin-based motility in cell extracts, similar to those
behaviors displayed by the pathogenic bacterium
Listeria monocytogenes. In extracts depleted of the
Arp2/3 complex, WASP-coated microspheres and
L. monocytogenes were non-motile and exhibited only
residual actin polymerization. These results
demonstrate that WASP is sufficient to direct actin-
based motility in cell extracts and that this function is
mediated by the Arp2/3 complex. WASP interacts with
diverse signaling proteins and may therefore function
to couple signal transduction pathways to
Arp2/3-complex activation and actin polymerization. 
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Results and discussion 
The actin-nucleating activity of the Arp2/3 complex is
stimulated up to 50-fold by the L. monocytogenes cell-
surface protein ActA [8]. This suggests that a eukaryotic
cellular factor possessing an activity similar to that of ActA
might regulate actin polymerization during cell motility by
modulating the activity of the Arp2/3 complex. No such
factor has yet been identified, however.
We tested whether purified recombinant human WASP
tagged with the FLAG epitope (FLAG–WASP; Figure 1d)
could stimulate the capacity of the Arp2/3 complex to
accelerate actin polymerization. Actin-assembly kinetics
were monitored using the pyrene–actin assay [10,11]. The
polymerization of actin alone was characterized by an
initial lag phase, indicative of the kinetic barrier to nuclea-
tion, followed by a period of more rapid filament elonga-
tion (Figure 1a). Although WASP induces actin
polymerization when microinjected into cells [4] and is
thought to bind actin monomers in vitro [9], FLAG–WASP
had no detectable affect on polymerization kinetics under
the conditions tested (Figure 1a). As was observed pre-
viously, the Arp2/3 complex alone caused a modest accele-
ration of polymerization relative to the control, but failed to
eliminate or reduce the lag phase [7,8]. Addition of increas-
ing amounts of FLAG–WASP with a fixed concentration of
the Arp2/3 complex, however, caused a dose-dependent
acceleration of actin polymerization (Figure 1b). At the
highest concentrations of WASP (a WASP:Arp2/3-complex
molar ratio of 4:1), the initial rate of actin assembly was up
to 35-fold higher than that in the reactions with the Arp2/3
complex or WASP alone, and the lag phase of polymeriza-
tion was eliminated (Figure 1c). Thus, WASP stimulates
the activity of the Arp2/3 complex, and the Arp2/3 complex
and WASP together are sufficient for actin-filament nucle-
ation. This suggests that WASP may influence the spatial
and temporal distribution of actin polymerization in cells
by modulating the activity of the Arp2/3 complex. 
We sought to examine further the function of WASP in a
context that more closely resembled the conditions inside a
living cell. The effect of WASP on the nucleating activity
of the Arp2/3 complex was nearly identical to that of ActA,
the L. monocytogenes surface protein that is necessary [12,13]
and sufficient to direct actin polymerization in cell cyto-
plasm [14–16]. We therefore examined whether WASP-
coated beads were sufficient to induce actin polymerization
in cell extracts. FLAG–WASP was bound to 1 µm diameter
protein-A-conjugated microspheres coated with anti-FLAG
antibody. These microspheres were incubated in bovine-
brain-extract high-speed supernatant that was sup-
plemented with rhodamine-labeled actin to allow actin
structures to be visualized by fluorescence microscopy.
Clouds of polymerized actin were observed at the surface
of 59 ± 4% (range 48–69%; n = 417) FLAG–WASP-coated
beads (Figure 2a,b). A smaller percentage (34 ± 4%; range
21–44%) of FLAG–WASP-coated beads formed actin tails
(Figure 2a,b), which were similar in morphology to the tails
formed by L. monocytogenes in the same extracts. Control
beads coated with an unrelated FLAG-tagged protein
(FLAG–Smad3 [17]) did not induce actin polymerization in
extracts (Figure 2c,d), indicating that the ability to poly-
merize actin is specific to WASP. 
Because actin-tail formation accompanies L. monocytogenes
motility, we used time-lapse microscopy to observe whether
tail formation by FLAG–WASP microspheres also correlated
with movement. FLAG–WASP microspheres moved at an
average rate of 0.2 µm/minute (Figure 2e), which was three
times slower than the mean rate of L. monocytogenes motility
in the extract (0.6 ± 0.1 µm/minute). The discrepancy in
motility rates may be caused by differences in the size and
shape of the moving particles, by the distribution of WASP
or ActA on the surface of the particles, or by the fact that
ActA may be more efficient than WASP because it competes
with WASP for the Arp2/3 complex. Nevertheless, the
observation that WASP-coated microspheres polymerized
actin and moved in cell extracts indicates that WASP is suffi-
cient to direct actin-based motility in this context and sug-
gests that WASP functions in this capacity in cells. 
The biochemical interaction between WASP and the
Arp2/3 complex in vitro suggested that the ability of WASP
to induce actin polymerization in cell extracts was medi-
ated by the Arp2/3 complex. Similarly, the Arp2/3 complex
has been proposed to mediate the actin polymerization
that is induced by L. monocytogenes [6,8]. To determine the
functional importance of the Arp2/3 complex, it was
removed from extracts by immunodepletion using a
mixture of affinity-purified antibodies that recognize three
of the seven subunits of the complex: Arp3, p41-Arc and
p16-Arc. More than 95% of the Arp2/3 complex was
removed from the depleted extract when compared with
the control extract, which was mock-depleted using 
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Effects of the Arp2/3 complex and WASP on actin polymerization.
(a–c) Graphs of fluorescence intensity versus time after initiating
polymerization in the pyrene–actin assay [10,11]. (a) Curve 1, 2 µM actin;
curve 2, 2 µM actin with 80 nM FLAG–WASP; curve 3, 2 µM actin with
20 nM Arp2/3. (b) 2 µM actin and 20 nM Arp2/3 with varying
concentrations of FLAG–WASP, as indicated. (c) Expanded view of the
initial 120 sec of the graph in (b). (d) Purified FLAG–WASP visualized on
a 12% polyacrylamide gel containing SDS stained with Coomassie blue. 
Figure 2
Behavior of WASP–FLAG microspheres in
bovine-brain extract. (a,c,e) are fluorescence-
microscopy images; (b,d) are phase-contrast
images. (a) Composite image of rhodamine-
labeled actin structures formed by
FLAG–WASP microspheres incubated in
bovine-brain extract. (b) The same
FLAG–WASP microspheres as in (a).
(c) Composite image of rhodamine-labeled
actin structures formed by control
FLAG–Smad3 microspheres incubated in
bovine-brain extract. (d) The same
FLAG–Smad3 microspheres as in (c).
(e) Time-lapse images of a rhodamine-labeled
actin tail trailing behind a moving
FLAG–WASP bead in bovine-brain extract.
Images were taken at 150 sec intervals. The
arrow indicates the original position of the
microsphere. The scale bar represents 10 µm. 
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nonspecific rabbit immunoglobulin G (Figure 3g). In the
control extract, a high percentage of FLAG–WASP micros-
pheres (Figure 3a,h) and L. monocytogenes (Figure 3d,i)
polymerized actin clouds and tails. Depletion of the
Arp2/3 complex abolished actin tail formation by
FLAG–WASP microspheres (Figure 3b,h) and L. mono-
cytogenes (Figure 3e,i). Moreover, depletion greatly reduced
the size and fluorescence intensity of actin clouds
(Figure 3b,e). Residual actin, which appeared as a faint
outline, was observed at the surface of many beads
(Figure 3b,h), and a small number of bacteria (Figure 3e,i).
The residual actin may have been polymerized by Arp2/3
complex remaining in the extract after depletion (<5% of
the endogenous pool), or by other unknown factors. More-
over, in the case of FLAG–WASP microspheres, residual
actin may have been bound directly by WASP. 
To demonstrate that the effect of Arp2/3-complex deple-
tion on actin polymerization was indeed caused by the
removal of the Arp2/3 complex, purified Arp2/3 complex
was added back to the depleted extracts. Addition of the
Arp2/3 complex at a concentration comparable to endoge-
nous levels (Figure 3g) restored the ability of
FLAG–WASP beads to polymerize actin clouds and tails
in extracts (Figure 3c,h), although, in general, tails were
shorter and less abundant than in the control mock-
depleted extract. Addition of Arp2/3 complex completely
restored actin-cloud and actin-tail formation by L. mono-
cytogenes (Figure 3f,i). The lower level of rescue of
FLAG–WASP-microsphere-based actin-tail formation
suggests that bead motility may be more sensitive than
L. monocytogenes motility to removal and replacement of
the Arp2/3 complex, perhaps because of a physical prop-
erty of the beads or a more stringent requirement for other
factors in the extract. In either case, these findings indi-
cate that the Arp2/3 complex is necessary for actin-based
motility and robust actin polymerization by FLAG–WASP
microspheres and L. monocytogenes in bovine-brain extracts. 
Our results demonstrate that WASP is sufficient to direct
actin-polymerization-based motility in cell extracts. More-
over, we have shown that WASP works in concert with the
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Figure 3
The effect of Arp2/3-complex depletion on
WASP-bead and L. monocytogenes motility.
(a–c) Composite images of actin structures
formed by FLAG–WASP microspheres.
WASP microspheres are shown false colored
in blue, and rhodamine-labeled actin is shown
in red. (a) Actin tails and clouds in control
mock-depleted bovine-brain extract; (b)
residual actin in Arp2/3-complex-depleted
extract and (c) actin tails and clouds in
Arp2/3-complex-depleted extract
supplemented with pure Arp2/3 complex.
(d–f) Composite images of actin structures
formed by L. monocytogenes. Bacteria are
shown labeled with DAPI in blue, and actin
labeled with rhodamine in red. (d) Control
mock-depleted bovine-brain extract; (e)
Arp2/3-complex-depleted extract; (f) Arp2/3-
complex-depleted extract supplemented with
pure Arp2/3 complex. The scale bar for (a–f)
represents 10 µm. (g) Immunoblot of bovine-
brain extract probed with antibodies against
the Arp2/3 complex components p34-Arc and
p21-Arc. Lane 1, mock-depleted extract; Lane
2, Arp2/3-complex-depleted extract; Lane 3,
Arp2/3-complex-depleted extract
supplemented with pure Arp2/3 complex.
(h,i) Graphs illustrating the percentage of (h)
WASP beads or (i) L. monocytogenes that
formed actin clouds (gray), residual clouds
(white) and tails (black) in (1) mock-depleted
extract, (2) Arp2/3-complex-depleted extract
and (3) Arp2/3-complex-depleted extract
supplemented with pure Arp2/3 complex.
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Arp2/3 complex, both in vitro and in cell extracts, to stimu-
late actin nucleation. WASP may participate indirectly in
nucleation by inducing a conformational change in the
Arp2/3 complex, or directly by providing an additional
binding interface for actin. Regulation of the interaction
between WASP and the Arp2/3 complex may be a central
control mechanism for modulating the spatial and tempo-
ral distribution of actin polymerization in cells. Mutations
in the WASP gene cause defects in platelet morphology,
macrophage chemotaxis [2,3,5], T-lymphocyte activation
and antigen-receptor capping [18]. Actin nucleation by the
Arp2/3 complex and WASP may thus be critical for these
cellular functions. Diverse WASP-family proteins, which
include N-WASP [19] and WAVE/Scar [20,21], may serve
to differentially regulate the Arp2/3 complex in distinct
cell types. Interestingly, although L. monocytogenes ActA
may mimic WASP-family proteins, the Shigella flexneri
equivalent, IcsA/VirG, appears to recruit N-WASP to
harness the host’s actin cytoskeleton [22]. 
WASP contains multiple binding sites for proteins involved
in signal transduction, suggesting that it may function to
integrate information from a diverse set of signals to acti-
vate the Arp2/3 complex and actin polymerization. One
WASP binding partner is the Rho-family GTPase Cdc42
(reviewed in [23]), which can induce actin polymerization
mediated by the Arp2/3 complex at the surface of beads in
cell extract [24]. We have been unable to detect any effect
of activated Cdc42 on actin nucleation by WASP and the
Arp2/3 complex, however (M.D.W. and A.A., unpublished
observations). Cdc42 may work to regulate the localization
of WASP to the plasma membrane or to sites where rapid
polymerization is required. The activity and localization of
WASP may also be regulated by signalling pathways
involving tyrosine kinases (reviewed in [23,25]). Thus,
multiple pathways may act in concert to regulate the activ-
ity of WASP-family proteins and the Arp2/3 complex, and
delineation of this set of regulatory interactions will help to
elucidate the molecular mechanisms of cell morphogene-
sis, cell locomotion and Wiskott-Aldrich syndrome. 
Supplementary material
Additional methodological details are published with this article on
the internet.
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Supplementary materials and methods 
Purification of the Arp2/3 complex and WASP
The Arp2/3 complex was purified as described previously [S1,S2].
Recombinant human FLAG–WASP was expressed in Sf-9 insect cells
using the baculovirus system. FLAG–WASP was partially purified from
cell lysates by binding to anti-FLAG monoclonal-antibody M2 affinity
gel (Eastman Kodak) and eluting with FLAG peptide (Eastman Kodak).
Eluted protein was further purified by chromatography on a MonoQ
column (Amersham Pharmacia Biotech) and subsequently on a
superdex-200 column (Amersham Pharmacia Biotech) equilibrated
with control buffer for the pyrene–actin assay [S3]. 
Pyrene–actin assay 
The pyrene–actin assay was carried out as described previously [S3]
with the following exception: monomeric actin that was isolated by cen-
trifugation was further purified by chromatography on a superdex-200
column (Amersham Pharmacia Biotech) equilibrated with G buffer [S3].
Preparation of WASP microspheres 
Monoclonal M2 anti-FLAG antibody (12 µg) was bound to 10 µl of
1 µm diameter protein-A-conjugated microspheres (Bangs Laborato-
ries). Microspheres were washed into extract buffer (20 mM HEPES
pH 7.7, 50 mM KCl, 2 mM MgCl2, 5 mM EGTA, 1 mM EDTA, 100 mM
sucrose). Of the 10 µl sample of microspheres, 5 µl were incubated
with 5 µg FLAG–WASP and the other 5 µl with 8 µg FLAG–Smad3
protein [S4]. Coated microspheres were washed and resuspended in
extract buffer. 
WASP-microsphere and L. monocytogenes assays 
Frozen bovine brain was pulverized and ground in liquid nitrogen, then
mixed with an equal volume of extract buffer supplemented with
0.5 mM ATP, 1 mM leupeptin, 1 mM chymostatin, 1 mM pepstatin and
0.5 mM DTT. Brain high-speed supernatant was obtained by centrifu-
gation at 100,000 × g for 15 min (final protein concentration 7 mg/ml).
Similar extracts have been used to study L. monocytogenes motility
[S5,S6]. To assay for actin polymerization and motility, microspheres or
DAPI-labelled L. monocytogenes [S2] were incubated in brain extract
supplemented with actin labeled with N-hydroxysuccinimidyl 5-car-
boxytetramethyl rhodamine (1 µM) as described previously [S1,S2],
except that 0.5% methyl cellulose was also added. 
Antibody preparation and immunodepletion 
A polyclonal antibody that recognizes the isoform of p41-Arc that is
expressed in brain, Sop2Hs [S7], was made by immunizing rabbits with
the synthetic peptide CKTLESSIQGLRIM (in the single-letter amino-
acid code), which corresponds to the carboxy-terminal 13 amino acids
of Sop2Hs. An anti-human-Arp3 antibody was made by immunizing
rabbits with the peptide CKRTVDARLKLSEELSGGRLKPK, which cor-
responds to amino acids 340–361 of Arp3. An anti-human-p16-Arc
antibody was made by immunizing rabbits with the peptide CKGFE-
SPSDNSSAMLLQ, which corresponds to amino acids 112–127 of
p16-Arc. Peptide-conjugation, antibody affinity-purification and antibody
storage procedures were performed as described previously [S8]. 
For immunodepletion, random rabbit IgG (90 µg; Jackson Laborato-
ries), or a combination of anti-Sop2Hs antibody (27 µg), anti
Arp3(340–361) antibody (42 µg), and anti-p16(112–127) antibody
(35 µg) was bound to 50 µl Affiprep protein-A beads (BioRad Labs).
Beads were washed with extract buffer and then incubated with 60 µl
bovine-brain high-speed supernatant for 40 min at 4°C. Beads were
pelleted and the supernatant was subjected to one or two more rounds
of depletion, yielding the depleted extract. For rescue, 0.2–1 µl of puri-
fied Arp2/3 complex was added to the depleted extract. The amount of
added Arp2/3 complex was quantified by immunoblotting using anti-
bodies to p34-Arc and p21-Arc [S9]. 
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